Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Varian Medical Systems, commonly referred to as Varian, is a leading player in the healthcare technology sector, headquartered in the United States. Founded in 1948, the company has established itself as a pioneer in radiation oncology, providing innovative solutions for cancer treatment. With a strong presence in North America, Europe, and Asia, Varian focuses on advanced medical devices and software that enhance cancer care.
The company’s core offerings include radiotherapy systems, software for treatment planning, and comprehensive patient management solutions. Varian's commitment to precision and efficiency sets its products apart in the competitive landscape. Recognised for its contributions to the field, Varian has achieved significant milestones, including the development of cutting-edge technologies that improve patient outcomes. As a trusted name in oncology, Varian continues to shape the future of cancer treatment globally.
+10 vs industry average
Varian’s score of 27 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Metal Fabrication is among the most carbon-intensive industries
The Metal Fabrication industry has reduced its overall emissions by 40% since 2018
Scope 3 accounts for ••• of total emissions.
In 2018, Varian Medical Systems, Inc. reported total carbon emissions of approximately 606.6 million kg CO2e. This figure includes Scope 1 emissions of about 21.5 million kg CO2e, Scope 2 emissions of approximately 9.0 million kg CO2e, and significant Scope 3 emissions totalling around 576.0 million kg CO2e. The Scope 3 emissions breakdown reveals major contributions from purchased goods and services (about 293.8 million kg CO2e) and the use of sold products (approximately 121.0 million kg CO2e).
Varian has set ambitious reduction targets, aiming to decrease its carbon footprint by a minimum of 25% from a 2010 baseline by 2020. This target applies to both Scope 1 and Scope 2 emissions, reflecting a commitment to reducing greenhouse gas emissions across its operations.
As a current subsidiary of Siemens Healthineers AG, Varian's climate initiatives and performance data are cascaded from its parent company. This relationship underscores Varian's alignment with broader corporate sustainability goals and practices within the healthcare technology sector.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more